Market Cap: $60.32B
Market Cap: $60.32B
Open
$14.88
Prev. Close
$15.43
High
$14.90
Low
$14.52
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments.
Bayer AG trades on the Other OTC under the ticker BAYRY, priced in USD.
Bayer AG has a market capitalisation of $60.32B, based on its latest share price.
BAYRY has no meaningful P/E ratio because it reported a loss over the last 12 months.
Over the past 52 weeks BAYRY has traded between $7.65 and $15.98.
Yes. Bayer AG's dividend yields 0.24% at the current share price.
Loss-making over the last 12 months (net margin -3.8%).
The analyst consensus rating for BAYRY is Hold.
Bill Anderson is the CEO of Bayer AG, which is headquartered in Leverkusen.
Generated automatically from reported financial data. General information only, not financial advice.
Bayer AG Poised to Benefit from U.S. Defense Production Act for Herbicides In a decisive move highlighting a shift towards strengthening domestic agricultural production, President Donald Trump signs…
U.S. DPA move on glyphosate and phosphorus places strategic spotlight on Bayer AG A presidential order invoking the Defense Production Act to boost domestic supplies of elemental phosphorus and glypho…
Bayer presses $10.5 billion plan to resolve Roundup cancer litigation Bayer AG is pushing a $10.5 billion settlement package to resolve current and future U.S. lawsuits alleging its Roundup weedkiller…
Bayer moves to cap Roundup litigation with $10.5 billion settlement package Bayer AG announces a proposed $10.5 billion package to resolve current and future U.S. lawsuits that allege its Roundup weed…